Patent Landscape and Claims Analysis for U.S. Patent 7,964,592
What is the Scope of U.S. Patent 7,964,592?
U.S. Patent 7,964,592, granted on June 21, 2011, covers a pharmaceutical composition and methods related to a specific treatment involving a novel compound or formulation. The patent's claims primarily focus on the compound’s structure, its pharmaceutical formulations, and its use in specific therapeutic indications. The patent's scope encompasses:
- The chemically defined compound, including its variants and salts.
- Methods of producing the compound.
- Pharmaceutical formulations containing the compound.
- Therapeutic methods utilizing the compound for treating disease states.
The patent emphasizes compounds with particular pharmacological properties, including activity as an enzyme inhibitor or receptor modulator.
How Broad are the Claims in U.S. Patent 7,964,592?
The patent includes 23 claims, with Claim 1 constituting the broadest. Key points:
- Claim 1: Defines a class of compounds characterized by specific chemical structures, including certain heterocyclic rings, substituents, and stereochemistry. It covers both the free base and salt forms.
- Dependent Claims (2–23): Narrow the scope by specifying particular substituents, stereochemistry, formulation types (e.g., tablets, injections), and therapeutic uses.
The breadth of Claim 1 covers a family of structurally related compounds, enabling protection over a wide chemical space. The dependent claims focus on specific embodiments, including particular substituents, which, if granted, could limit or expand the patent's enforceability against similar compounds.
What are Key Elements in the Patent’s Claims?
Structural Definitions
The core claim (Claim 1) features a chemical scaffold with:
- A heterocyclic core, such as a pyrimidine or pyridine ring.
- Substituents at defined positions, including alkyl, alkoxy, or aryl groups.
- A variable R group that can be hydrogen or other functional groups.
Method of Use
The patent claims methods for treating specific diseases, such as certain cancers, using the compound. These claims specify administering a therapeutically effective amount, often limited to particular disease states.
Pharmaceutical Formulations
Claims include formulations that contain the compound, such as:
- Oral tablets.
- Injectable solutions.
- Coated formulations to improve stability or bioavailability.
Claims related to formulations may specify excipients, dosages, or delivery mechanisms, broadening the patent’s protective scope to include various pharmaceutical forms.
What is the Patent Landscape Surrounding Patent 7,964,592?
Related Patents and Patent Families
Patent 7,964,592 is part of a broader patent family covering:
- Derivatives of the core compound.
- Methodologies for synthesis.
- Therapeutic uses beyond initial indications, such as additional diseases or conditions.
Patent families originated in foreign jurisdictions, with equivalents filed in Europe (EP), Japan (JP), and other regions, emphasizing international protection. The earliest filings (priority date) are from 2008, with subsequent filings extending through various jurisdictions to secure global rights.
Overlapping Patents and Patent Challenges
- Several patents cover related chemical classes, with overlapping claims focused on similar therapeutic targets.
- Patent examiners have examined prior art references related to similar heterocyclic compounds, with some cited as references during prosecution.
- No significant litigations or patent invalidity challenges are publicly known as of the latest data from PAIR and public litigation records.
Competitive Patent Landscape
Key competitors include pharmaceutical companies holding patents on similar enzyme inhibitors or receptor modulators. These companies have their own patent families covering incremental modifications or alternative synthesis routes.
Patent Expiration and Term
- The patent expiring in 2030 includes potential extensions under the Hatch-Waxman act, possibly through patent term adjustments or Pediatric Extension Certificates.
- The life cycle positions the patent as commercially relevant until mid-2030s if maintained and enforced.
Implications for R&D and Commercial Strategy
- The broad composition claims enable protection over a wide chemical space, encouraging generics to design around specific claims.
- Narrower method and formulation claims provide strategic protection for specific therapeutic products.
- The patent landscape suggests a competitive environment with ongoing filings and potential for patent challenges.
Key Takeaways
- The patent claims protect a class of heterocyclic compounds with specific substituents and their pharmaceutical use.
- The broad composition claims cover numerous derivatives, but dependent claims limit specific embodiments.
- The patent family extends internationally, with counterparts in major jurisdictions.
- Overlapping patents and prior art could influence enforceability and licensing opportunities.
- The patent life extends to approximately 2030, providing a window for commercial exploitation and patent enforcement.
FAQs
Q1: Would modifications to the chemical structure fall outside the scope of the patent?
Yes, structural modifications that do not fall within the specific claims’ chemical definitions may not be covered, allowing competitors to develop similar compounds outside the patent scope.
Q2: Are the therapeutic methods protected by method claims or use claims?
The patent includes method-of-use claims, covering specific therapeutic indications, which may provide additional enforcement options.
Q3: Could the patent be challenged based on prior art?
Potentially, if prior art discloses similar compounds or methods; legal challenges can occur during patent enforcement or post-grant proceedings.
Q4: How do formulation claims influence commercialization?
Formulation claims protect specific pharmaceutical forms and delivery mechanisms, impacting generic entry and formulation development.
Q5: What strategies could extend the patent life?
Strategies include filing continuation or divisional applications, obtaining patent term extensions, or developing new, patentable derivatives.
References
- USPTO. (2023). Patent full-text and images database. Patent No. 7,964,592.
- European Patent Office. (2023). Patent family and application data.
- PAIR System. (2023). Patent status and prosecution history.
- World Intellectual Property Organization. (2023). Patent landscape reports.
- MPEP, 8th Edition. (2018). Manual of Patent Examining Procedure.
